Response to Letter to ‘Serum <scp>CRP</scp> in Durvalumab‐Tremelimumab‐Treated <scp>HCC</scp> : Expanding the Inflammatory Narrative’

Authors

Institutions

Publication Details

Journal
Liver International
Published
2025-10-16
DOI
https://doi.org/10.1111/liv.70381
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Response to Letter to ‘Serum CRP in Durvalumab‐Tremelimumab‐Treated HCC : Expanding the Inflammatory Narrative’

Takeshi Hatanaka, Takashi Kumada, Yutaka Yata, Satoru Kakizaki
Liver International
Liver Disease Diagnosis and Treatment
article

Response to Letter to ‘Serum CRP in Durvalumab‐Tremelimumab‐Treated HCC : Expanding the Inflammatory Narrative’

Takeshi Hatanaka, Takashi Kumada, Yutaka Yata, Satoru Kakizaki
article en

Abstract

No abstract available for this paper.
Liver InternationalVol. 45(11)
National Hospital Organization Takasaki Medical Center (JP), Hanwa Memorial Hospital (JP), Gunma Saiseikai Maebashi Hospital (JP), Osaka Metropolitan University (JP), Gifu Kyoritsu University (JP), Tokyo Metropolitan University (JP)
Openalex Percentile: Top 61%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.